Table 1 Baseline characteristics of participants completing the study (N = 44)
Age, years, mean (SD) | 49.3 (14.5) |
Male sex, N (%) | 37 (84%) |
White race* | 30 (68%) |
Black or other race* | 14 (32%) |
Education level, N (%) | |
 Less than high school | 1 (2%) |
 High school or more | 43 (98%) |
Age at first gout flare (years)†, mean (SD) | 38.3 (18.6) |
Duration of gout (years)†, mean (SD) | 10.5 (7.9) |
Number of flares in prior 6 months, N (%) | |
 2–3 | 19 (43%) |
 ≥ 4 | 25 (57%) |
Gout medication use, N (%)* | |
 Urate-lowering therapy | 37 (84%) |
 NSAID or colchicine | 28 (64%) |
 Prednisone | 13 (30%) |
Number of smartphone applications on cellphone†, mean (SD) | 21.2 (16.1) |